Vice President, CMC & Drug-Delivery Innovation
Listed on 2026-10-21
-
Management
Healthcare Management, Project & Program Management
Kailera Therapeutics is a late clinical-stage biotechnology company advancing GLP-1-based therapies for obesity. The Vice President, CMC Drug & Device Development will own the strategy and execution across drug substance, drug product, device and combination products, spanning late-stage development to regulatory filing and commercial launch readiness.
Reporting to the Chief Technology Officer, the VP will lead a growing CMC organization and collaborate with Regulatory Affairs, Quality,
The Vice President, CMC & Drug-Delivery Innovation role at Kailera Therapeutics is now open for applications in Waltham, MA, United States.
We aim to respond to suitable candidates as soon as possible.
Full responsibilities and requirements are described in the listing above.
Learn more about the Vice President, CMC & Drug-Delivery Innovation role in the description above.
We appreciate your interest in this position.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).